Keystone Financial Group (Kentucky)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Keystone Financial Group (Kentucky)'s NVO Position: Q2 2026 in Review
Keystone Financial Group (Kentucky) opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,320 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #520 among its holdings. This is a return to the name: Keystone Financial Group (Kentucky) previously reported a position in NVO as recently as Q2 2025.
Keystone Financial Group (Kentucky) first reported a position in NVO in Q1 2024 and has held it in 6 quarters since. The position peaked at $406K in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Keystone Financial Group (Kentucky) held 4,320 shares of Novo Nordisk worth $207K as of Q2 2026.
- Novo Nordisk was a new Keystone Financial Group (Kentucky) position in Q2 2026.
- Novo Nordisk made up 0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #520 holding.
- Keystone Financial Group (Kentucky) first reported a position in Novo Nordisk in Q1 2024 and has held it in 6 quarters since.
- Keystone Financial Group (Kentucky)'s Novo Nordisk position peaked at $406K in Q2 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.